SHELDON KAPLAN to Follow-Up Studies
This is a "connection" page, showing publications SHELDON KAPLAN has written about Follow-Up Studies.
Connection Strength
0.144
-
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005 May; 24(5):457-8.
Score: 0.031
-
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children. Pediatr Infect Dis J. 2003 Aug; 22(8):677-86.
Score: 0.027
-
Follow-up Blood Cultures in Children With Staphylococcus aureus Bacteremia. Pediatrics. 2020 12; 146(6).
Score: 0.023
-
Hepatosplenic abscesses due to Brucella melitensis: report of a case involving a child and review of the literature. Clin Infect Dis. 1996 Mar; 22(3):485-9.
Score: 0.016
-
Presumed central nervous system Whipple's disease in a child: case report. Clin Infect Dis. 1995 Apr; 20(4):883-9.
Score: 0.015
-
Follow-up of prospective randomized trial of ampicillin or chloramphenicol versus moxalactam treatment of Haemophilus influenzae type b meningitis. J Pediatr. 1988 May; 112(5):795-8.
Score: 0.010
-
Citrobacter diversus and neonatal brain abscess. Pediatr Neurol. 1987 May-Jun; 3(3):178-80.
Score: 0.009
-
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
Score: 0.007
-
Treatment of acute otitis media consensus recommendations. Clin Pediatr (Phila). 2002 Jul-Aug; 41(6):373-90.
Score: 0.006